Position in DGX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$19,075
+$2,417 QoQ
Shares Held
90
+5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#963
of 1,096 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cornerstone Planning Group LLC holds $456,394 across 18 Diagnostics & Research names. DGX ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
207 | $103,781 | |
| 2 | DHR |
Danaher Corp /De/
|
372 | $70,858 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
122 | $64,225 | |
| 4 | A |
Agilent Technologies, Inc.
|
307 | $40,778 | |
| 5 | WGS |
GeneDx Holdings Corp.
|
400 | $27,460 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
139 | $26,857 | |
| 7 | DGX |
Quest Diagnostics Inc
This page
|
90 | $19,075 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
36 | $19,065 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,075 | 90 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $16,658 | 85 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $11,626 | 67 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $71 | 4 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,083 | 45 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,768 | 40 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,262 | 15 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||